Ulrich Wiesmann

4.6k total citations
170 papers, 3.6k citations indexed

About

Ulrich Wiesmann is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Ulrich Wiesmann has authored 170 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 45 papers in Physiology and 29 papers in Clinical Biochemistry. Recurrent topics in Ulrich Wiesmann's work include Lysosomal Storage Disorders Research (29 papers), Metabolism and Genetic Disorders (27 papers) and Health, psychology, and well-being (20 papers). Ulrich Wiesmann is often cited by papers focused on Lysosomal Storage Disorders Research (29 papers), Metabolism and Genetic Disorders (27 papers) and Health, psychology, and well-being (20 papers). Ulrich Wiesmann collaborates with scholars based in Switzerland, Germany and United States. Ulrich Wiesmann's co-authors include N. Herschkowitz, Hans‐Joachim Hannich, Ulrich E. Honegger, H P Siegrist, Tadeus Nawka, Elizabeth F. Neufeld, Hans‐Uwe Simon, Stephan Krähenbühl, Bendicht Wermuth and Christine Talos and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Ulrich Wiesmann

168 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrich Wiesmann Switzerland 33 1.5k 999 445 361 321 170 3.6k
Nelly Mauras United States 53 2.1k 1.4× 1.2k 1.2× 140 0.3× 646 1.8× 139 0.4× 182 8.7k
Marie Lambert Canada 40 1.1k 0.7× 962 1.0× 662 1.5× 157 0.4× 393 1.2× 143 5.0k
Anna Hansson Sweden 11 1.3k 0.9× 1.7k 1.7× 321 0.7× 55 0.2× 193 0.6× 18 2.9k
Carlo Vergani Italy 37 808 0.5× 860 0.9× 82 0.2× 226 0.6× 255 0.8× 143 3.8k
S R Srinivasan United States 47 1.3k 0.9× 1.5k 1.5× 61 0.1× 993 2.8× 535 1.7× 143 7.6k
Osamu Takikawa Japan 51 2.0k 1.4× 684 0.7× 94 0.2× 165 0.5× 54 0.2× 127 8.7k
Ruth D. Lipman United States 29 962 0.7× 921 0.9× 82 0.2× 133 0.4× 392 1.2× 96 4.0k
Sumiko Yoshida Japan 36 1.5k 1.0× 1.0k 1.0× 83 0.2× 141 0.4× 114 0.4× 150 4.4k
Dennis Bourdette United States 56 1.6k 1.1× 606 0.6× 82 0.2× 118 0.3× 140 0.4× 251 9.2k
Tatsuyuki Kakuma Japan 45 1.5k 1.0× 628 0.6× 211 0.5× 127 0.4× 308 1.0× 233 6.8k

Countries citing papers authored by Ulrich Wiesmann

Since Specialization
Citations

This map shows the geographic impact of Ulrich Wiesmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Wiesmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Wiesmann more than expected).

Fields of papers citing papers by Ulrich Wiesmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Wiesmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Wiesmann. The network helps show where Ulrich Wiesmann may publish in the future.

Co-authorship network of co-authors of Ulrich Wiesmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Wiesmann. A scholar is included among the top collaborators of Ulrich Wiesmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Wiesmann. Ulrich Wiesmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiesmann, Ulrich, et al.. (2022). A short form of the posttraumatic growth and posttraumatic depreciation inventory - expanded (PTGDI-X-SF) among German adults.. Psychological Trauma Theory Research Practice and Policy. 15(5). 838–845. 6 indexed citations
2.
Wiesmann, Ulrich, et al.. (2022). Coping and rumination as predictors of posttraumatic growth and depreciation. Chinese Journal of Traumatology. 25(5). 264–271. 15 indexed citations
3.
Piontek, Katharina, Ulrich Wiesmann, Christian Apfelbacher, Henry Völzke, & Hans J. Grabe. (2021). The association of childhood maltreatment, somatization and health-related quality of life in adult age: Results from a population-based cohort study. Child Abuse & Neglect. 120. 105226–105226. 17 indexed citations
4.
Wiesmann, Ulrich & Hans‐Joachim Hannich. (2008). A salutogenic view on subjective well-being in active elderly persons. Aging & Mental Health. 12(1). 56–65. 62 indexed citations
5.
Nawka, Tadeus, et al.. (2003). Validierung des Voice Handicap Index (VHI) in der deutschen Fassung. HNO. 51(11). 921–930. 176 indexed citations
6.
Suormala, Terttu, Ulrich Wiesmann, Fátima Cruz, et al.. (2002). Biotin-Dependent Carboxylase Activities in Different CNS and Skin-Derived Cells, and their Sensitivity to Biotin-Depletion. International Journal for Vitamin and Nutrition Research. 72(4). 278–286. 12 indexed citations
7.
Wiesmann, Ulrich, et al.. (1996). Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphophilic drugs in human cultured cells. British Journal of Pharmacology. 119(5). 829–834. 26 indexed citations
8.
Wiesmann, Ulrich, et al.. (1987). Sulfated glycosaminoglycans (GAG) in the developing mouse brain. Developmental Biology. 120(2). 447–456. 17 indexed citations
9.
Wiesmann, Ulrich, et al.. (1984). Atypical metachromatic leukodystrophy?. Human Genetics. 67(2). 170–173. 5 indexed citations
10.
Caimi, Luigi, et al.. (1983). Metabolism of sulfogalactosyl glycerolipids in the myelinating mouse brain. Developmental Biology. 98(1). 182–186. 11 indexed citations
11.
Wiesmann, Ulrich, et al.. (1981). Net sulfatide synthesis, galactosylceramide sulfotransferase and arylsulfatase a activity in the developing cerebrum and cerebellum of normal mice and myelin-deficient jimpy mice. Biochimica et Biophysica Acta (BBA) - General Subjects. 673(3). 351–358. 9 indexed citations
12.
Caimi, Luigi, A. Lombardo, Augusto Preti, Ulrich Wiesmann, & Guido Tettamanti. (1979). Optimal conditions for the assay of fibroblast neuraminidase with different natural substrates. Biochimica et Biophysica Acta (BBA) - Enzymology. 571(1). 137–146. 31 indexed citations
13.
Gitzelmann, R, Ulrich Wiesmann, M. A. Spycher, N. Herschkowitz, & A Giedion. (1978). Unusually mild course of beta-glucuronidase deficiency in two brothers (mucopolysaccharidosis VII).. PubMed. 33(4-5). 413–28. 5 indexed citations
14.
Wiesmann, Ulrich & N. Herschkowitz. (1974). Studies on the Pathogenetic Mechanism of I-Cell Disease in Cultured Fibroblasts. Pediatric Research. 8(11). 865–870. 69 indexed citations
15.
Wiesmann, Ulrich, et al.. (1971). The Whirlpool Corporation. 2 indexed citations
17.
Wiesmann, Ulrich & Elizabeth F. Neufeld. (1970). Metabolism of sulfated mucopolysaccharide in cultured fibroblasts from cystic fibrosis patients. The Journal of Pediatrics. 77(4). 685–690. 15 indexed citations
18.
Wiesmann, Ulrich, et al.. (1970). Ultrastructure of cultivated fibroblasts in cystic fibrosis of the pancreas. The Journal of Pediatrics. 76(3). 430–437. 23 indexed citations
19.
Wiesmann, Ulrich, Thomas F. Boat, & Paul A. di Sant' Agnese. (1970). Sodium concentration in unstimulated parotid saliva and on oral mucosa in normal subjects and in patients with cystic fibrosis. The Journal of Pediatrics. 76(3). 444–448. 15 indexed citations
20.
Moser, Hans, Ulrich Wiesmann, R. Richterich, & Eleonora Rossi. (1964). [PROGRESSIVE MUSCULAR DYSTROPHY. VI. INCIDENCE, CLINICAL ASPECTS AND GENETICS OF THE DUCHENNE TYPE].. PubMed. 94. 1610–21. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026